Live Breaking News & Updates on நாஸ்டாக் முதல் வடக்கு வளர்ச்சி

Stay updated with breaking news from நாஸ்டாக் முதல் வடக்கு வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Modus Therapeutics Appoints Sedermera Fondkommission as Financial Advisor to Support Planned Listing on Nasdaq First North Growth Market


Modus Therapeutics Appoints Sedermera Fondkommission as Financial Advisor to Support Planned Listing on Nasdaq First North Growth Market
- Listing to fund the clinical development of sevuparin for sepsis/septic shock
- No pharmaceutical products are currently available that are specifically meant to treat patients with sepsis/septic shock
News provided by
Share this article
STOCKHOLM, March 15, 2021 /PRNewswire/
Modus Therapeutics Holding AB, a company developing innovative treatments for patients with high unmet medical needs, announces that it has appointed Sedermera Fondkommission as financial adviser to support its planned listing on Nasdaq First North Growth Market. The engagement of Sedermera Fondkommission follows the appointment of Claes Lindblad at Modus Therapeutics as its new Chief Financial Officer. ....

Claes Lindblad , Sedermera Fondkommission , Citigate Dewe Rogerson , Prnewswire Modus Therapeutics Holding , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Foundation For Baltic , Nasdaq First North Growth , Modus Therapeutics , Chief Financial , Nasdaq First North Growth Market , Nasdaq Stockholm , Rosetta Capital , European Studies , David Dible , Citigate Dewe , அடித்தளம் க்கு பால்டிக் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி , மோடஸ் சிகிச்சை , தலைமை நிதி , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , ரொசெட்டா மூலதனம் , ஐரோப்பிய ஆய்வுகள் , டேவிட் டிபிலே ,

InDex Pharmaceuticals updates shareholders list


InDex Pharmaceuticals updates shareholders list
News provided by
Share this article
STOCKHOLM, March 12, 2021 /PRNewswire/
InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders on the homepage has been updated with information as of February 26, 2021.
The 15 largest shareholders in InDex Pharmaceuticals Holding AB (publ) were as of February 26, 2021:
                                   
Publication
The information was submitted for publication through the agency of the contact person set out above at 13:45 CET on March 12, 2021.
InDex Pharmaceuticals in brief
InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The Company s lead asset is the drug candidate cobitolimod, which is in late stage clinical development for the treatment of moderate to severe ulcerative colitis - a ....

Staffan Rasj , Stiftelsen Industrifonden , Nordnet Pensionsf , Se Bankens Utvecklingsstiftelse , Peter Zerhouni , Life International , Prnewswire Index Pharmaceuticals Holding , Kindex Pharmaceuticals , Index Pharmaceuticals Holding , Company Certified Adviser , Avanza Pension , Dex Pharmaceuticals , Immunomodulatory Sequences , Nasdaq First North Growth , வாழ்க்கை சர்வதேச , குறியீட்டு மருந்துகள் , குறியீட்டு மருந்துகள் வைத்திருத்தல் , அவன்ச ஓய்வூதியம் , டெக்ஸ் மருந்துகள் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி ,

Crypto asset manager CoinShares begins trading on Nasdaq in Sweden

Crypto asset manager CoinShares begins trading on Nasdaq in Sweden
theblockcrypto.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theblockcrypto.com Daily Mail and Mail on Sunday newspapers.

Jean Marie Mognetti , Nasdaq First North Growth , Swedish Krona , Nasdaq Stockholm , Marie Mognetti , Nasdaq Nordic , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி , ஸ்விட்ச் குரோனா , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , நாஸ்டாக் நோர்டிக் ,